Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,830 | 78,241 | 100,444 | 94,570 | 117,705 |
| Marketable Securities | 76,271 | 127,146 | 177,188 | 218,998 | 198,017 |
| Receivables | 3,935 | 8,049 | 4,472 | 5,046 | 6,291 |
| TOTAL | $159,609 | $227,087 | $300,327 | $336,621 | $343,120 |
| Non-Current Assets | |||||
| PPE Net | 60,717 | 59,877 | 63,531 | 55,986 | 53,499 |
| Investments And Advances | 39,037 | 35,610 | 29,845 | 36,700 | 47,966 |
| Intangibles | 0 | 51,555 | 88,281 | 80,950 | 86,231 |
| Other Non-Current Assets | 65,711 | 66,438 | 80,525 | 83,656 | 86,310 |
| TOTAL | $165,465 | $213,480 | $262,182 | $257,292 | $274,006 |
| Total Assets | $325,074 | $440,567 | $562,509 | $593,913 | $617,126 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,837 | 19,920 | 22,418 | 17,380 | 13,076 |
| Accrued Expenses | 13,118 | 12,949 | 21,506 | 19,045 | 13,913 |
| TOTAL | $53,792 | $57,839 | $111,711 | $122,361 | $119,987 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,873 | 9,575 | 51,780 | 71,890 | 78,794 |
| Other Non-Current Liabilities | 37,640 | 38,930 | 40,193 | 41,017 | 42,815 |
| TOTAL | $37,640 | $47,118 | $155,840 | $162,398 | $178,858 |
| Total Liabilities | $91,432 | $104,957 | $267,551 | $284,759 | $298,845 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 177,112 | 171,826 | 168,483 | 163,880 | 156,553 |
| Common Shares | 1,771 | 1,718 | 1,668 | 1,619 | 1,534 |
| Retained earnings | -1,241,918 | -1,127,412 | -1,148,545 | -1,096,572 | -1,043,417 |
| Other shareholders' equity | -5,936 | -5,758 | -8,404 | -18,998 | -13,160 |
| TOTAL | $233,642 | $335,610 | $294,958 | $309,154 | $318,281 |
| Total Liabilities And Equity | $325,074 | $440,567 | $562,509 | $593,913 | $617,126 |